Metraipolis › archive › dc_11be1df89637
Molecular PET and immuno-PET in gastric cancer immunotherapy: current evidence, clinical utilities, and translational barriers — Europe PMC PMID:42148115
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42148115
- DOI
- 10.3389/fimmu.2026.1838846
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T21:25:04.060Z
- SHA-256 of the archived text
d59b2cd4870f736db62e7d5a29db8dcd26145062a8aea1f33a8394c459515092- Stable URL of this page
https://metraipolis.com/documento/dc_11be1df89637
How to cite
Molecular PET and immuno-PET in gastric cancer immunotherapy: current evidence, clinical utilities, and translational barriers — Europe PMC PMID:42148115 — Europe PMC (en), https://europepmc.org/article/MED/42148115 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11be1df89637 (Metraipolis archive dc_11be1df89637, sha256 d59b2cd4870f736db62e7d5a29db8dcd26145062a8aea1f33a8394c459515092)
BibTeX
@misc{dc11be1df89637,
title = {Molecular PET and immuno-PET in gastric cancer immunotherapy: current evidence, clinical utilities, and translational barriers — Europe PMC PMID:42148115},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42148115},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11be1df89637; sha256 d59b2cd4870f736db62e7d5a29db8dcd26145062a8aea1f33a8394c459515092},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148115. Agents can read the archived copy with the MCP tool read_document.